Special Issue "Nucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials"
A special issue of Nanomaterials (ISSN 2079-4991).
Deadline for manuscript submissions: closed (15 June 2019).
A printed edition of this Special Issue is available here.
Interests: programmable RNA and DNA nanoassemblies for controlled immunoregulation; biosensing; drug delivery
Special Issues and Collections in MDPI journals
Nucleic acids (RNA and DNA) and their chemical analogs have been utilized as building materials due to their biocompatibility and programmability. RNA, which naturally possesses a wide range of different functions, is now widely investigated for its role as a responsive biomaterial which dynamically reacts to changes in the surrounding environment. It is now evident that artificially designed self-assembling RNAs that can form programmable nanoparticles and supra-assemblies will play an increasingly important part in a diverse range of applications such as macromolecular therapies, drug delivery systems, biosensing, tissue engineering, programmable scaffolds for material organization, logic gates, and soft actuators, just to name a few.
We anticipate a very exciting issue composed of research highlights, short communications, research articles, and reviews that will bring together the leading scientists who are exploring a wide range of the fundamental properties of RNA nanoassemblies suitable for biomedical applications. Areas of interest include (but are not limited to) the following:
- RNA-based nanoparticles for therapeutic applications
- Programmable RNA-based biosensors
- RNA-based logic gates
- RNA-based supra-assemblies
- Dynamic RNA nanoparticles: concepts, design, and characterization
- In vivo delivery of novel RNA nanomaterials
- Immunological properties of novel RNA nanomaterials
- Interactions of RNA nanoparticles with other classes of biological molecules (proteins, lipids, etc.)
- Quantitative Structure-Activity Relationships in RNA nanomaterials
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Co-transcriptional assembly
- RNA nanoparticles
- DNA nanoparticles
- Therapeutic Nucleic Acids (TNA), Aptamers
- Nucleic Acids-based biosensors
- in vivo delivery of TNA